Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.

Bastiaan J ViergeverDaniëlle A E RaatsVeerle GeurtsJasper MullendersTrudy N JongesMichiel S Van Der HeijdenJohan H van EsOnno W Kranenburg Richard P Meijer

Published in: British journal of cancer (2023)

Therefore, urinoids can advance precision medicine in bladder cancer as a non-invasive platform for tumour pathogenesis, longitudinal drug-response monitoring, and therapy adaptation.

Keyphrases

cross sectional
papillary thyroid
high throughput
mesenchymal stem cells
squamous cell
bone marrow
drug induced
cell therapy
adverse drug
single cell